Literature DB >> 21120600

Reversed urban-rural differences in breast cancer mortality (China, 2002-2008).

Min He1, Qulian Guo, Guoqing Hu.   

Abstract

The purpose of this study was to examine the urban-rural difference in breast cancer mortality between 2002 and 2008 in China. A longitudinal analysis of mortality data was performed. Mortality data were extracted from Chinese Health Statistics Yearbook. Linear regression was used to examine the statistical significance of linear trend in mortality rates. The percent change in rates was used to measure the linear trend, which was calculated as regression coefficient × 100 × 6 divided by the rate of 2002. Between 2002 and 2008, the mortality from breast cancer increased by 201% among urban women (P < 0.05) while among rural women the rate did not show the significant increase, thus resulting in a reversed urban-rural difference (from -2.3/100,000 population in 2002 to 3.6 in 2008). Subgroup analysis showed that the reversed urban-rural difference was completely due to substantial increases among urban women aged 55-59 years and aged 75 years and above. In addition, significant decreases of breast cancer mortality were observed in urban women aged 35-49 years and in rural women aged 35-39 years (P < 0.05). The reversed urban-rural difference in breast cancer mortality during 2002-2008 is primarily caused by the increases among elderly urban women. Further studies are needed to understand the increases and to develop cost-effective interventions for elderly urban women in China.

Entities:  

Mesh:

Year:  2010        PMID: 21120600     DOI: 10.1007/s10549-010-1276-2

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  9 in total

1.  The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer.

Authors:  Xiaohong Xie; Yuanyuan Hu; Leilai Xu; Yongqing Fu; Jue Tu; Hong Zhao; Shuo Zhang; Ri Hong; Xidong Gu
Journal:  Tumour Biol       Date:  2015-04-17

2.  The Hippo Transducer YAP/TAZ as a Biomarker of Therapeutic Response and Prognosis in Trastuzumab-Based Neoadjuvant Therapy Treated HER2-Positive Breast Cancer Patients.

Authors:  Jia-Qi Yuan; Nian-Hua Ding; Zhi Xiao
Journal:  Front Pharmacol       Date:  2020-08-27       Impact factor: 5.810

3.  Circulating MiR-125b as a marker predicting chemoresistance in breast cancer.

Authors:  Hongjiang Wang; Guang Tan; Lei Dong; Lei Cheng; Kejun Li; Zhongyu Wang; Haifeng Luo
Journal:  PLoS One       Date:  2012-04-16       Impact factor: 3.240

4.  Secular Trends of Breast Cancer in China, South Korea, Japan and the United States: Application of the Age-Period-Cohort Analysis.

Authors:  Zhenkun Wang; Junzhe Bao; Chuanhua Yu; Jinyao Wang; Chunhui Li
Journal:  Int J Environ Res Public Health       Date:  2015-12-04       Impact factor: 3.390

5.  Gambogenic acid alters chemosensitivity of breast cancer cells to Adriamycin.

Authors:  Ye He; Jie Ding; Yan Lin; Juan Li; Yongguo Shi; Juan Wang; Ya Zhu; Keming Wang; Xuezhen Hu
Journal:  BMC Complement Altern Med       Date:  2015-06-12       Impact factor: 3.659

6.  Female Breast Cancer Mortality Clusters in Shandong Province, China: A Spatial Analysis.

Authors:  Jie Chu; Chengchao Zhou; Xiaolei Guo; Jiandong Sun; Fuzhong Xue; Jiyu Zhang; Zilong Lu; Zhentao Fu; Aiqiang Xu
Journal:  Sci Rep       Date:  2017-03-07       Impact factor: 4.379

7.  Women's cancers in China: a spatio-temporal epidemiology analysis.

Authors:  Rongxin He; Bin Zhu; Jinlin Liu; Ning Zhang; Wei-Hong Zhang; Ying Mao
Journal:  BMC Womens Health       Date:  2021-03-20       Impact factor: 2.809

8.  Temporal Trends in Geographical Variation in Breast Cancer Mortality in China, 1973-2005: An Analysis of Nationwide Surveys on Cause of Death.

Authors:  Changfa Xia; Clare Kahn; Jinfeng Wang; Yilan Liao; Wanqing Chen; Xue Qin Yu
Journal:  Int J Environ Res Public Health       Date:  2016-09-28       Impact factor: 3.390

9.  Cathepsin L interacts with CDK2-AP1 as a potential predictor of prognosis in patients with breast cancer.

Authors:  Zhan Wang; Zhen Xiang; Ting Zhu; Juan Chen; Mei-Zuo Zhong; Juan Huang; Kuan-Song Wang; Ling Li; Lun-Quan Sun; Wei-Bing Zhou
Journal:  Oncol Lett       Date:  2019-11-07       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.